biomarkapd general assembly, april 2015
TRANSCRIPT
![Page 1: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/1.jpg)
Joint Programming in
Neurodegenerative Disease Research (JPND)
Coordinating approaches to research across Europe
Derick Mitchell
BIOMARKAPD General Assembly
24/4/2015
![Page 2: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/2.jpg)
Overcoming European barriers
• Fragmented Research
• Non-concerted National Funding
• Duplication
• Shared research exists via EC
(< 5% of total EU budget)
![Page 3: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/3.jpg)
JPND brings together
• Researchers (Basic, Clinical, Healthcare/Social)
• National Funding Bodies
• National Research Strategies and Investments
![Page 4: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/4.jpg)
We cannot tackle neurodegenerative
diseases by acting as single countries
Albania
Austria
Belgium
CanadaCroatia
Czech Republic
Denmark
Finland
France
Germany
Greece
Hungary
Ireland
Israel
Italy
Luxembourg
NetherlandsNorway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
United Kingdom
JPND is the largest global ND research initiative
led by EU countries, with 28 participating
EU member states
Associated countries
Third countries
Increasing coordination of national
research programmes to improve
impact and effectiveness
A European Research Area and beyond
Australia TBC
![Page 5: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/5.jpg)
Defragmentation
– what JPND is all about…
STRATEGIC RESEARCH AGENDA
ALIGNMENT OF EU COUNTRIES
ON COMMON RESEARCH GOALS
![Page 6: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/6.jpg)
JPND Actions to date
• Common European Strategy (2012)
• Phase I Implementation (‘12-’14)
• Joint Transnational Calls (6)
• Alignment Actions (9)
• National Plans and Strategies
• Communication + Dissemination
![Page 7: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/7.jpg)
SRA Implementation (2012-2014)
Annual Calls for Proposals
Year Total fund Research Area No. of Projects
2011(pilot)
€16MOptimization of biomarkers + harmonization of their use
4
2012 €18M Risk and Protective Factors 5
2012 €11M Evaluation of Healthcare 6
2013 €12M Cross-Disease Analysis 10
2013 €11M Preventive Strategies 5
2014 €0.5M Working Groups Cohort Studies 10
2015 €30MLongitudinal Cohort Approaches;Advanced Experimental Models;
Risk and Protective Factors.
Closed March 10th
AG
![Page 8: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/8.jpg)
JPND Annual Call Statistics
Year Call area of interest
No. of
proposals
submitted
Budget
requested
(million €)
No. of proposals
recommended for
funding
No. of
proposals
supported
Budget
supported
(million €)
Success
rate (%)
2011 Harmonization of Biomarkers 14 €31 5 4 €14 29%
2012 Risk and Protective Factors 52 €97 18 5 €17 10%
2012 Healthcare Evaluation 22 €29 9 6 €9 27%
2013 Cross-Disease Analysis 90* €112 23 10 €12.5 11%
2013 Pilot Preventive Strategies 35* €36 5 5 €7 14%
Total 213 €157m 60 30 €59.5m 18%
* pre-proposals
![Page 9: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/9.jpg)
SRA Implementation
JPND Alignment Actions
![Page 10: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/10.jpg)
Action Group Recommendations
![Page 11: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/11.jpg)
“Rapid Action” Call for working groups
![Page 12: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/12.jpg)
Global action against dementia G7/WHO
![Page 13: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/13.jpg)
Fostering greater collaboration
Join our Online Partnering ToolIT
18%
DE16%
ES9%
UK9%
FR5%
PT5%
SE4%
CA4%
NO3%
BE3%
PL3%
IE2%
NL2%
LU2%
FI2%
DK2%
CH2%
AU2%
OTHERS5%
953 Profiles
38 Countries
![Page 14: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/14.jpg)
Dissemination and Communication
Guidelines
Updated October 2014
![Page 15: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/15.jpg)
Acknowledgement of support
![Page 16: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/16.jpg)
National-level reference New
![Page 17: BIOMARKAPD General Assembly, April 2015](https://reader030.vdocuments.mx/reader030/viewer/2022020307/55abc5b11a28ab195e8b4751/html5/thumbnails/17.jpg)
Keep up to date
• Visit the JPND website:
• http://www.jpnd.eu
• Sign up to the JPND News Feeds
• E-mail us: [email protected]
@JPNDEurope